Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
16

Bausch + Lomb Introduces PreserVision® AREDS 2 Formula + Multivitamin



 New Product Combines the Benefits of an AREDS2 Formula Supplement with a Daily Multivitamin to Offer Consumers Greater Convenience

 

FOR RELEASE THURSDAY, JUNE 16, 2016  

 

BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced the introduction of PreserVision® AREDS 2 Formula + Multivitamin. PreserVision® is the first leading brand to combine the AREDS2 study formula with other essential vitamins and minerals typically found in daily multivitamins. This convenient 2-in-1 formula helps make it simpler for consumers to take their supplements by reducing the number of pills taken each day.

 

“We are proud to offer consumers greater convenience by providing one supplement that includes the benefits of a daily multivitamin, with the added benefit of the National Eye Institute (NEI) recommended formula from the AREDS2 study found in PreserVision® AREDS 2 Formula,” said Joe Gordon, general manager, Valeant Consumer Healthcare. “We hope that PreserVision® AREDS 2 Formula + Multivitamin makes it easier for people to add PreserVision®, as recommended by their eye care professional, to their current regimen of supplements that often includes a daily multivitamin.

 

New PreserVision® AREDS 2 Formula + Multivitamin is beta carotene-free and contains a high level of Vitamin D to support the needs of older adults. The product was created in response to consumer feedback and data, which showed that 90 percent of the participants in the AREDS2 clinical study who took an AREDS supplement also took a daily multivitamin.1 In addition, as we age the use of multivitamin supplements increases, with regular use climbing higher than 50 percent after age 50 and continuing upward to encompass a solid majority of seniors over age 65.2

 


PreserVision®, the #1 doctor-recommended eye vitamin brand, is based on two major clinical studies known as AREDS and AREDS2. The NEI recommends people with moderate to advanced age-related macular degeneration (AMD) take a supplement with a specific combination of antioxidants and zinc based on the AREDS2 study. 

PreserVision® AREDS 2 Formula + Multivitamin is now available in major retailers, including Walgreens, Rite Aid, Kroger and Amazon.

 

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Our core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry, which is available in more than 100 countries.


References

1.     Chew, EY, et al. The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1). Ophthalmology. 2012 Nov; 119(11): 2282–2289.

2.     Results from a Gallup poll, based on telephone interviews conducted Dec. 6-9, 2013, on the Gallup Daily tracking survey, with a random sample of 2,023 adults, aged 18 and older, living in all 50 U.S. states and the District of Columbia.

 

PreserVision is a registered trademark of Bausch & Lomb Incorporated or its affiliates. AREDS and AREDS2 are registered trademarks of The U.S. Department of Health and Human Services (HHS). Any other product/brand names are trademarks of their respective owners. © 2016 Bausch & Lomb Incorporated.


 

News Media Contacts:

Kristy Marks
Sr. PR Product Manager, Bausch + Lomb

(908) 927-0683 or kristy.marks@bausch.com

 

Don Murphy

Zeno Group, on behalf of Bausch + Lomb

(212) 299-8970 or don.murphy@zenogroup.com

 

PV2.0051.USA.16

Actions: E-mail | Permalink |